interferoninduc
transmembran
protein
inhibit
hiv
siv
infect
stage
host
cell
entri
howev
still
unclear
extent
antivir
activ
observ
cell
cultur
translat
inhibit
hivsiv
spread
infect
host
shown
previous
although
inhibit
siv
entri
cultur
cell
polymorph
gene
strongli
associ
viral
load
diseas
progress
siv
infect
macaqu
examin
whether
close
relat
sequenc
level
exert
antivir
activ
whether
polymorph
gene
impact
cours
siv
infect
show
express
interferoninduc
inhibit
siv
entri
cell
although
reduc
effici
compar
report
identif
polymorph
gene
howev
analysi
well
character
cohort
siv
infect
macaqu
reveal
none
polymorph
signific
impact
upon
cours
siv
infect
result
previou
work
suggest
polymorph
gene
strongli
modul
cours
siv
infect
macaqu
plo
one
http
death
aidsrel
symptom
posit
interferon
ifn
system
integr
compon
innat
immun
constitut
first
line
defens
viral
infect
antivir
effect
ifn
respons
due
ifninduc
express
approxim
gene
mani
encod
protein
exert
antivir
activ
ifninduc
transmembran
protein
identifi
screen
host
cell
factor
modul
influenza
viru
fluav
infect
inhibit
host
cell
entri
fluav
sever
viral
pathogen
inhibit
viral
entri
believ
occur
stage
hemifus
fusion
pore
format
may
entail
alter
biophys
properti
membran
turn
may
requir
ifitmifitm
interact
importantli
intact
essenti
defens
sever
influenza
indic
protein
exert
potent
antivir
activ
infect
host
sever
line
evid
suggest
might
impact
hivsiv
infect
shown
inhibit
host
cell
entri
hiv
siv
incorpor
viral
particl
reduc
viral
infect
moreov
evid
provid
interfer
process
viral
envelop
protein
env
host
cell
proteas
essenti
viral
infect
final
demonstr
transmitterfound
virus
success
trespass
mucos
barrier
establish
hiv
infect
upon
sexual
transmiss
highli
resist
inhibit
studi
also
show
import
ifninduc
inhibit
hiv
infect
cultur
primari
cell
collect
result
indic
might
pose
barrier
sexual
transmiss
hivsiv
might
modul
viral
spread
infect
host
howev
direct
proof
role
hivsiv
amplif
host
diseas
progress
still
lack
shown
previous
rhesu
macaqu
rh
homologu
human
hu
inhibit
siv
entri
transfect
cell
identifi
polymorph
gene
three
locat
exon
howev
none
polymorph
significantli
modul
peak
viral
load
diseas
progress
macaqu
cohort
experiment
infect
siv
cours
studi
also
identifi
homologu
term
gene
locat
chromosom
encod
protein
share
sequenc
ident
fig
howev
exhibit
two
amino
acid
differ
highli
conserv
central
part
also
found
protein
may
thu
differ
antivir
activ
fig
whether
inhibit
siv
infect
present
unknown
show
express
ifninduc
inhibit
siv
envdriven
entri
target
cell
although
modest
effici
howev
polymorph
gene
found
strongli
impact
cours
siv
infect
human
embryon
kidney
dsmz
acc
rhesu
macaqu
cell
line
smagi
mammari
tumor
telorf
telomeraseimmort
fibroblast
kidney
epithelium
kidney
cultiv
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
lglutamin
penicillinstreptomycin
humidifi
atmospher
co
smagi
telorf
cell
obtain
collabor
cell
gener
cours
present
studi
plasmid
encod
murin
leukemia
viru
envelop
protein
mlvenv
siv
envelop
protein
env
fluav
strain
hemagglutinin
ha
neuraminidas
na
describ
previous
gener
express
plasmid
env
xhoiecori
fragment
contain
env
sequenc
subclon
provir
dna
invitrogen
mlvbase
retrovir
vector
pqcxip
encod
human
macaqu
protein
chloramphenicol
acetyltransferas
cat
control
well
mlvluc
mlvgagpol
vsvg
express
plasmid
report
previous
mutat
version
carri
mutat
gener
splice
overlap
pcr
use
primer
templat
final
pcr
product
digest
noti
ecori
clone
pqcxipmc
ident
pcramplifi
sequenc
verifi
use
autom
sequenc
publish
protocol
use
gener
mlv
particl
encod
ifitm
cat
protein
transduct
experi
briefli
cell
flask
cotransfect
pqcxip
vector
harbor
ifitm
gene
cat
mlvgagpol
vsvg
plasmid
medium
chang
h
supernat
harvest
h
post
transfect
pass
filter
aliquot
store
mlv
report
particl
pseudotyp
differ
viral
env
protein
analysi
entri
inhibit
ifitm
protein
produc
way
use
mlvluc
mlvgagpol
respect
envelopeencod
plasmid
particl
bear
fluav
surfac
protein
plasmid
ha
na
use
mlv
luc
plasmid
contain
hcmv
enhancerpromot
mlvltr
control
region
follow
gagless
packag
signal
full
ltr
element
deriv
friend
murin
leukemia
viru
firefli
luciferas
cdna
control
hcmv
enhancerpromot
insert
packag
signal
antivir
activ
ifitm
protein
assess
describ
previous
briefli
cell
seed
plate
cell
per
well
medium
next
day
transduc
particl
ad
per
well
follow
spinocul
min
two
day
medium
replac
fresh
cell
cultur
medium
follow
transduct
mlv
particl
harbor
viral
glycoprotein
analyz
ifitm
sensit
normal
equal
luciferas
activ
upon
transduct
cohort
sivinfect
macaqu
macaca
mulatta
indian
origin
screen
retrospect
polymorph
cohort
use
previous
search
polymorph
modul
aidsfre
surviv
time
viral
load
siv
infect
macaqu
either
bred
german
primat
center
known
ancestri
origin
breeder
franc
unit
kingdom
unit
state
three
anim
pcramplif
success
genet
phenotyp
data
remain
anim
summar
tabl
anim
infect
intraven
intrarect
via
tonsil
singl
dose
display
whole
spectrum
diseas
progress
rapid
progress
longterm
nonprogress
combin
viru
infect
rout
definit
earli
aidsdefin
ill
base
upon
clinic
necropsi
histopatholog
find
describ
anim
hous
german
primat
center
dpz
condit
accord
german
anim
protect
act
european
union
guidelin
use
nonhuman
primat
biomed
research
describ
experi
approv
extern
ethic
committe
author
lower
saxoni
state
offic
consum
protect
food
safeti
project
licens
accord
german
anim
welfar
act
dpz
permit
breed
hous
nonhuman
primat
licens
number
issu
local
veterinari
author
macaqu
daili
surveil
veterinarian
anim
caretak
quarantin
anim
usual
hous
group
anim
per
cage
minimum
enclosur
height
cm
cage
volum
experi
anim
hous
singli
cage
dimens
cm
constant
visual
olfactori
acoust
contact
roommat
procedur
anim
welfar
minim
discomfort
suffer
undertaken
accord
recommend
weatheral
report
use
nonhuman
primat
research
monkey
fed
dri
monkey
biscuit
supplement
fresh
fruit
veget
twice
daili
fresh
water
access
ad
libitum
environment
enrich
anim
offer
feed
puzzl
vari
toy
wood
stick
gnaw
addit
music
play
dna
prepar
blood
sampl
drawn
anesthesia
mg
ketamin
im
per
kg
bodi
weight
anim
human
euthan
overdos
pentobarbitalnatrium
merial
hallbergmoo
germani
anesthesia
either
experiment
reason
without
exhibit
clinic
symptom
case
suffer
predefin
score
system
termin
criteria
approv
extern
ethic
committe
correspond
iacuc
endpoint
guidelin
describ
purpos
studi
monkey
sacrif
sinc
archiv
sampl
use
gene
amplifi
genom
dna
pcr
screen
polymorph
sequenc
primer
amplif
base
upon
macaca
mulatta
chromosom
scaffold
use
success
amplif
cdna
gene
amplif
perform
primer
specif
amplif
sequenc
primer
pair
confirm
sequenc
anlaysi
sinc
forward
primer
ident
use
amplif
gene
also
test
differ
forward
primer
contain
sever
mismatch
gene
forward
primer
howev
sequenc
result
show
differ
amplif
indic
high
specif
reaction
mixtur
contain
ng
genom
dna
pmol
primer
dntp
mix
betain
hf
synthesi
buffer
u
phusion
dna
polymeras
thermofish
pcr
cycl
start
min
denatur
follow
cycl
denatur
anneal
elong
min
conclud
min
elong
cool
amplif
product
separ
agaros
gel
purifi
sequenc
directli
primer
use
sequenc
strand
amplicon
assembl
scaffold
sequenc
use
vector
nti
contigexpress
polymorph
identifi
visual
inspect
total
cellular
rna
smagi
telorf
cell
either
controltr
treat
h
uml
univers
type
interferon
pbl
assay
scienc
extract
use
rneasi
mini
kit
qiagen
hilden
germani
follow
manufactur
instruct
next
rna
treat
dnase
new
england
biolab
ipswich
usa
use
cdna
synthesi
use
superscript
iii
firststrand
synthesi
system
thermofish
scientif
waltham
usa
follow
manufactur
instruct
oligodt
strategi
final
quantit
pcr
perform
employ
quantitect
sybr
green
pcr
kit
qiagen
hilden
germani
separ
reaction
includ
cdna
total
volum
cdna
synthesi
primer
target
housekeep
gene
control
myxoviru
resist
protein
interferonstimul
gene
prepar
primer
sequenc
avail
upon
request
analyz
rotorgen
q
platform
qiagen
hilden
germani
induct
gene
express
follow
stimul
ifn
analyz
ctmethod
refer
gene
display
express
fold
chang
analysi
protein
express
cell
seed
well
plate
cell
per
well
medium
next
day
transduc
particl
ad
per
well
follow
spinocul
min
subsequ
replac
fresh
medium
two
day
medium
remov
cell
lyse
ad
sd
lysi
buffer
sd
glycerin
bromophenol
blue
edta
tri
ph
well
sampl
heat
min
separ
polyacrylamid
gel
subsequ
protein
blot
onto
nitrocellulos
membran
ge
healthcar
miniprotean
tetra
cell
biorad
v
minut
membran
block
skim
milk
dilut
tween
h
room
temperatur
primari
antibodi
ad
skim
tween
incub
night
polyclon
rabbit
antihuman
proteintech
group
mous
monoclon
sigma
use
primari
antibodi
wash
tween
room
temperatur
min
membran
incub
antirabbit
antimous
hrp
horseradish
peroxidas
conjug
secondari
antibodi
dianova
one
hour
wash
three
time
tween
protein
band
detect
use
chemiluminesc
substrat
hrp
juic
plu
pjk
visual
use
chemocam
imag
inta
aidsfre
surviv
analysi
perform
use
lifetest
procedur
sa
softwar
version
sa
institut
inc
cari
nc
viru
load
associ
polymorph
assess
statist
signific
mannwhitney
test
two
genotyp
kruskalw
test
three
genotyp
appropri
use
graphpad
prism
softwar
graphpad
la
jolla
usa
pvalu
twosid
level
statist
signific
mark
follow
p
p
p
first
assess
whether
ifninduc
gene
whether
like
abl
block
siv
entri
target
cell
end
incub
four
rhesu
macaqu
cell
line
smagi
telorf
measur
express
qrtpcr
found
treatment
markedli
stimul
express
two
known
ifnstimul
gene
least
fig
express
also
increas
upon
ifn
treatment
induct
express
rang
thu
express
ifninduc
might
contribut
control
viru
infect
therefor
next
studi
whether
interfer
host
cell
entri
driven
sivenv
protein
transfect
cell
express
siv
receptor
coreceptor
transduc
cell
vector
encod
human
rhesu
macaqu
ifitm
protein
subsequ
transduc
cell
luciferaseencod
murin
leukemia
viru
mlv
particl
bear
sivenv
parallel
examin
particl
harbor
env
protein
mlv
hemagglutinin
ha
fluav
well
known
mlv
envdriven
entri
larg
resist
inhibit
fluavhamedi
entri
highli
sensit
immunoblot
analysi
reveal
protein
analyz
express
transduc
cell
although
rel
express
higher
fig
fig
exhibit
slightli
differ
gel
migrat
present
unknown
might
reflect
differenti
posttansl
process
express
impact
transduct
mediat
mlvenv
markedli
reduc
transduct
driven
ha
fluav
strain
fig
expect
moreov
reduc
transduct
mediat
env
protein
macrophag
tropic
variant
agreement
previou
studi
fig
also
diminish
sivenv
fluavhadriven
entri
although
reduc
effici
compar
keep
previou
find
final
show
lower
detect
inhibitori
activ
compar
fig
potenti
due
reduc
express
former
fig
collect
result
indic
express
ifninduc
protein
exert
antivir
activ
siv
next
investig
whether
polymorph
previous
character
macaqu
coloni
compris
anim
pairwis
blood
related
confound
factor
minim
tabl
gene
local
chromosom
contain
two
exon
give
rise
predict
mrna
nt
genbank
entri
analysi
sequenc
pcr
strategi
follow
amplifi
bp
cover
whole
transcrib
region
subsequ
pcr
product
directli
subject
sequenc
analysi
identifi
polymorph
fig
two
polymorph
locat
code
region
exon
three
present
noncod
region
exon
remain
polymorph
intron
fig
polymorph
locat
noncod
region
singl
nucleotid
substitut
insert
delet
singl
base
one
instanc
five
base
also
observ
tabl
one
two
polymorph
locat
code
region
result
amino
acid
substitut
affect
one
two
posit
within
conserv
central
part
ifitm
ident
differ
code
prolin
posit
heterozygos
major
allel
frequenc
usual
respect
tabl
one
polymorph
c
low
heterozygos
three
major
allel
frequenc
includ
caus
amino
acid
exchang
final
test
whether
polymorph
impact
aidsfre
surviv
time
viral
load
siv
infect
macaqu
howev
statist
signific
associ
polymorph
aidsfre
surviv
fig
viru
load
fig
detect
also
assess
whether
polymorph
result
alter
antivir
activ
cell
cultur
howev
wt
compar
express
fig
inhibit
mlvenv
fluavha
sivenvdriven
host
cell
entri
similar
effici
fig
although
blockad
entri
somewhat
effici
measur
thu
may
appreci
impact
antivir
activ
collect
result
suggest
polymorph
gene
strongli
modul
antivir
activ
cell
cultur
alter
cours
siv
infect
experiment
inocul
macaqu
human
patient
harbor
particular
polymorph
gene
result
alter
splice
acceptor
site
previous
shown
suscept
sever
influenza
noncarri
patient
also
found
progress
faster
toward
aid
find
although
undisput
see
exampl
indic
polymorph
impact
cours
viral
infect
notion
recent
reinforc
find
polymorph
promot
reduc
express
increas
risk
sever
influenza
investig
whether
antivir
activ
whether
polymorph
impact
cours
siv
infect
show
inhibit
siv
envdriven
entri
cell
cultur
although
extent
gene
polymorph
final
provid
evid
polymorph
strongli
impact
cours
siv
infect
express
littl
impact
entri
driven
mlvenv
markedli
inhibit
entri
driven
fluavha
expect
similar
result
obtain
inhibit
effici
lower
moreov
blockad
siv
envdriven
entri
less
effici
differ
antivir
activ
could
due
reduc
express
compar
howev
note
specif
antibodi
use
detect
protein
analyz
conceiv
amino
acid
exchang
present
alter
antibodi
epitop
fact
previou
analys
conduct
protein
harbor
antigen
tag
reveal
effici
express
nevertheless
less
effici
inhibit
ebola
viru
indic
rhesu
macaqu
cell
line
incub
presenc
ifn
uml
h
controltr
transcript
level
actb
analyz
quantit
rtpcr
normal
transcript
level
refer
gene
differ
rel
number
transcript
ifnstimul
control
mock
treat
cell
calcul
ctmethod
includ
normal
actb
housekeep
gene
control
level
shown
express
fold
chang
result
singl
experi
perform
triplic
sampl
shown
confirm
separ
experi
error
bar
indic
standard
deviat
b
cell
transduc
express
indic
ifitm
protein
express
detect
immunoblot
use
polyclon
antibodi
rais
human
express
serv
load
control
similar
result
obtain
three
independ
experi
c
cell
transfect
express
rhesu
macaqu
gene
transduc
express
either
control
chloramphenicolacetyltransferas
cat
human
hu
rhesu
macaqu
rh
glycoproteindriven
entri
collect
result
indic
block
viral
entri
may
thu
contribut
inhibit
viral
spread
infect
host
antivir
activ
might
lower
display
sequenc
comparison
base
upon
rhesu
macaqu
genom
scaffold
agre
nice
previou
amplif
clone
cdna
analysi
polymorph
describ
recent
describ
scaffold
sequenc
switch
exon
downstream
observ
analys
howev
note
sever
polymorph
within
intron
sequenc
appear
present
result
intron
sequenc
calcul
haplotyp
gene
form
mix
tree
wherea
exon
sequenc
cluster
respect
refer
gene
regard
unlik
mix
due
pcr
artifact
addit
genespecif
polymorph
interspers
close
share
polymorph
recent
studi
sharma
colleagu
character
macaqu
ifitm
gene
use
evolutionaryand
genomicbas
approach
report
follow
gene
order
ifitm
locu
chromosom
order
agre
work
compton
colleagu
find
addit
note
exhibit
similar
genom
local
howev
dna
sequenc
level
part
includ
exon
base
upon
base
upon
use
sharma
et
al
differ
nucleotid
within
exon
distinct
polymorph
describ
sequenc
align
indic
part
base
upon
exchang
base
howev
would
abl
bind
sequenc
sequenc
ident
therefor
think
ifitmencod
region
chromosom
fulli
resolv
yet
experiment
result
agre
best
origin
assembl
sequenc
ident
within
amplifi
region
presenc
pseudogen
ifitm
locu
chromosom
addit
pseudogen
chromosom
highlight
pcr
condit
care
chosen
specif
amplif
previou
report
document
condit
specif
amplif
reli
upon
high
anneal
temperatur
exclus
pseudogen
differ
size
condit
serv
basi
establish
specif
pcr
use
primer
reaction
also
primer
adjust
sequenc
side
side
comparison
pcr
confirm
previous
report
sequenc
moreov
sequenc
amplifi
specif
pcr
differ
obtain
specif
pcr
match
document
confirm
pcr
genespecif
gene
found
polymorph
total
polymorph
observ
exon
intron
site
highli
polymorph
major
allel
frequenc
maf
homozyg
carrier
allel
detect
thu
polymorph
polymorph
identifi
six
maf
hand
mani
polymorph
cosegreg
therebi
yield
ident
result
surviv
viru
load
analys
polymorph
identifi
intron
may
thu
affect
gene
express
howev
impact
polymorph
rna
stabil
premrna
splice
exclud
context
noteworthi
none
polymorph
alter
splice
donor
acceptor
site
branch
point
five
polymorph
exon
two
locat
code
region
one
silent
could
nevertheless
impact
effici
translat
protein
fold
polymorph
result
amino
acid
substitut
maf
exchang
locat
close
intramembran
domain
integr
found
import
antifluav
activ
howev
substitut
impact
express
antivir
activ
least
transfect
cell
impact
polymorph
cours
siv
infect
analyz
use
well
character
anim
cohort
previous
allow
detect
associ
polymorph
surviv
time
context
siv
infect
analysi
sampl
reveal
none
polymorph
identifi
present
studi
significantli
associ
time
aid
develop
viral
load
exclud
analysi
much
larger
sampl
size
would
reveal
associ
howev
impact
respect
polymorph
siv
infect
like
low
appear
appreci
alter
outcom
experiment
siv
infect
macaqu
context
note
analys
conduct
siv
macaqu
sivmac
highli
adapt
macaqu
still
possibl
nonmacaqueadapt
sivsm
siv
sooti
mangabey
precursor
sivmac
highli
sensit
andor
factor
limit
crossspeci
transmissiona
scenario
describ
warrant
investig
case
ifitm
protein
well
collect
previou
studi
suggest
chang
sequenc
rare
occur
interfer
strongli
antivir
activ
keep
concept
gene
nonhuman
primat
underw
purifi
select
